InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,130.46
(
1.31%
)
US TECH 100
17,434.80
(
2.10%
)
Dow Jones
38,677.78
(
1.18%
)
Brent Oil
82.81
(
-0.99%
)
Bitcoin
61,753.98
(
4.45%
)
Post# of 251699
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119559
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 206072

Monday, 11/21/2016 5:31:42 PM

Monday, November 21, 2016 5:31:42 PM

Post# of 251699
Re: ENTA’s pro forma enterprise value

With 21.0M fully-diluted* shares, $242M in cash at 9/30/16 (#msg-126720369), no debt, and minuscule cash burn (so we may ignore the change since 9/30/16), ENTA’s enterprise value at today’s closing price of $30.07 is $390M.

If we further presume that ENTA will earn the $80M in milestones that ABBV must pay for regulatory approval of Glecaprevir/Pibrentasvir in the US, EU, and Japan, ENTA’s pro forma EV is only $310M. That’s cheap!

*Non-treasury method.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up